Marksans Pharma consolidated net profit rises 31.37% in the December 2022 quarter
Sales rise 32.32% to Rs 479.83 crore
Net profit of Marksans Pharma rose 31.37% to Rs 63.41 crore in the quarter ended December 2022 as against Rs 48.27 crore during the previous quarter ended December 2021. Sales rose 32.32% to Rs 479.83 crore in the quarter ended December 2022 as against Rs 362.63 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales479.83362.63 32 OPM %15.9715.94 -PBDT91.9468.91 33 PBT79.2060.35 31 NP63.4148.27 31Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 13 2023 | 2:08 PM IST